Delayed Presentation, Diagnosis, and Treatment of Breast Cancer Among Chinese Women: An Integrative Literature Review
- PMID: 35283469
- DOI: 10.1097/NCC.0000000000001074
Delayed Presentation, Diagnosis, and Treatment of Breast Cancer Among Chinese Women: An Integrative Literature Review
Abstract
Background: Delays before treatment initiation increase the likelihood of later-stage diagnosis of breast cancer and reduce survival. Among Chinese women living in mainland China, Hong Kong, and Taiwan, the amount of time lost in delay and the factors influencing it are unclear.
Objective: This integrative review aimed to characterize delay intervals among Chinese women, identify factors contributing to delay, and develop a conceptual model of these factors.
Methods: Using Whittemore and Knafl's methodology for integrative reviews, PubMed, CINAHL, Web of Science, SCOPUS, PsycINFO, and China National Knowledge Infrastructure were searched for primary research articles. For 15 selected studies, quality evaluation was performed employing the Crowe Critical Appraisal Tool. A narrative synthesis was developed to summarize and explain the findings.
Results: Total delay intervals (from first discovery of breast symptoms to treatment initiation) exceeded 3 months for 50.2% to 52% of breast cancer patients. The greatest delay occurred between symptom discovery and first presentation (patient intervals). Factors affecting delay in presentation, diagnosis, and treatment included symptom appraisal, Chinese cultural factors, knowledge of breast cancer symptoms and screening, health history, personality, social and healthcare factors, and background factors.
Conclusions: Half of Chinese breast cancer patients delayed long enough to lower their chances of survival. Our review sheds light on how the reviewed factors contribute to delay and their unique influences in this population.
Implications for practice: Factors identified can inform nursing interventions that raise breast cancer awareness and promote timely diagnosis and treatment in Chinese women.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
References
-
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin . 2021;71:209–249.
-
- Chen YP, Lu YW, Yang CC. Breast cancer trend in Taiwan. Womens Health . 2017;6(2):376–379.
-
- Hong Kong Cancer Registry. The incidence and mortality for the top 10 cancers in 2019. 2019. https://www3.ha.org.hk/cancereg/topten.html . Accessed September 30, 2021.
-
- International Agency for Research on Cancer. Global Cancer Observatory: cancer today. 2020. https://gco.iarc.fr/today/home . Accessed September 30, 2021.
-
- Caplan L. Delay in breast cancer: implications for stage at diagnosis and survival. Front Public Health . 2014;2:87.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
